Earnings History Data for Akari Therapeutics Plc (AKTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Akari Therapeutics Plc
Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22-09-2021 | PM | AKTX | Akari Therapeutics Plc | 86.15 | -0.11 | 0.00 | -0.28 | Akari Therapeutics reports Q2 results [9/22/2021 8:43 AM] |
1.72 | -0.04 (-2.39%) |
1.81 | 0.05 (2.84%) |
1.42 - 4.21 | 99,634 | 110,000 | 1,101 | ||
| 11-12-2020 | PM | 8:30 AM ET (Dec 11) |
AKTX | Akari Therapeutics Plc | 73.10 | 0.04 | 0.00 | -0.14 | Akari Therapeutics reports Q3 results [12/11/2020 11:35 AM] |
2.01 | 0.07 (3.61%) |
1.95 | 0.01 (0.52%) |
0.87 - 2.79 | 320,684 | 430,800 | 7,271 | |